Quality is our priority. We uphold the highest standards by leveraging process expertise, advanced clean rooms, and state-of-the-art systems. Our comprehensive value chain oversight, from seedlings to delivered raw materials, ensures meticulous monitoring at every stage. Supported by in-house analytics, we maintain strict quality compliance—from incoming goods inspection through all processes to the final release for customer shipment.
Active pharmaceutical ingredients (API) and custom-compounded medicinal solutions are pivotal in enhancing patient health and well-being. Since health is humanity’s most valuable asset, GlobeMed Pharma Group makes no compromises when it comes to quality. We are steadfast in our mission to supply the pharmaceutical market with APIs of unparalleled quality and reliability.
To achieve this, we strictly adhere to EU and PIC/S-GMP regulations. Furthermore, we implement and comply with the standards of the following authoritative references:
- Pharmacopeia Europea (Ph. Eur.)
- Pharmacopeia Helvetica (Ph. Helv.)
- German Pharmacopoeia (DAB)
- Medicinal Products Act (HMG)
- German Medicines Codex (DAC-NRF)
However, achieving excellence means going beyond regulatory compliance. True quality demands an ingrained commitment to the highest standards, shared by all participants across the value chain. Delivering exceptional outcomes requires unwavering discipline, collaboration, and a profound understanding of every step of the process.
At GlobeMed Pharma Group, quality begins at the foundation. It starts with the careful selection of superior raw material varieties, cultivated sustainably in our highly specialized proprietary environments and rigorous quality controls. We consistently maintain the highest level of strict guidelines and specifications, ensuring all production aligns with Good Agricultural and Collection Practices (GACP). Our team conducts regular inspections throughout every stage of cultivation to maintain these standards from seed to sale.
The commitment to excellence extends beyond cultivation. Post-harvest, raw materials are meticulously stored and transported under controlled conditions, safeguarding their quality. Upon arrival at GlobeMed Pharma Group, they are subjected to rigorous, pharmacopeia-compliant quality control. These materials are then processed at our advanced facilities, adhering to the strict requirements of pharmacopoeias and GMP standards, ensuring the final product—whether an active pharmaceutical ingredient or a custom medicinal formulation—meets the most exacting quality and safety standards.
By combining uncompromising regulatory adherence with a passion for excellence, GlobeMed Pharma Group ensures that every product we deliver supports better health outcomes for patients worldwide from seed to sale.
Email:
[email protected]
Stay up to date. In our newsletter we will inform you about our latest findings and developments. You will also gain exciting insights into our daily work.